H. Mason

Clinical stage drugs targeting inhibitor of apoptosis proteins purge episomal Hepatitis B viral genome in preclinical models

T. Mahmoudi, M. Pellegrini, H. Netter, 2021, Cell Death & Disease.

Secreted hepatitis B virus splice variants differ by HBV genotype and across phases of chronic hepatitis B infection

A. Gaggar, P. Revill, Susanna K. Tan, 2022, Journal of viral hepatitis.

Intrahepatic CXCL10 is strongly associated with liver fibrosis in HIV-Hepatitis B co-infection

S. Lewin, P. Revill, J. Torresi, 2020, PLoS pathogens.

The in vitro replication phenotype of hepatitis B virus (HBV) splice variant Sp1.

P. Revill, M. Littlejohn, V. Sozzi, 2022, Virology.

HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapy

Wei Zhao, S. Lewin, P. Revill, 2022, EBioMedicine.

Analysis of the in vitro replication phenotype of African hepatitis B virus (HBV) genotypes and subgenotypes present in Australia identifies marked differences in DNA and protein expression.

P. Revill, S. Locarnini, W. Hardikar, 2019, Virology.

HBeAg levels at week 24 predict response to 8 years of tenofovir in HBeAg‐positive chronic hepatitis B patients

M. Buti, P. Marcellin, H. Janssen, 2018, Alimentary pharmacology & therapeutics.